Isavuconazole as an adjunctive antifungal in the multimodal management of pulmonary aspergilloma and chronic cavitary pulmonary aspergillosis: a single-centre case series. (PubMed, Respir Med Case Rep) - Aug 20, 2026 - "In this small heterogeneous cohort, isavuconazole appeared well tolerated and was a feasible alternative to voriconazole when prolonged adjunctive therapy was required alongside bronchoscopic or medical management of pulmonary aspergilloma and CCPA. Larger comparative studies are needed to define its place in multimodal protocols."
Journal • Colorectal Cancer • Hepatology • Infectious Disease • Liver Failure • Oncology • Pulmonary Disease • Respiratory Diseases • Solid Tumor
|
|
Christina S Thornton; Christopher H Mody; Elaine Dumoulin; Meagan Deviaene; Ranjani Somayaji
|